Colonic resection or self-expanding metal stents for obstructive left colon cancer: results of a national multicenter prospective cohort study (CROSCO-1) - Summary - MDSpire

Colonic resection or self-expanding metal stents for obstructive left colon cancer: results of a national multicenter prospective cohort study (CROSCO-1)

  • By

  • Alessio Giordano

  • Manuela Mastronardi

  • Paola Fugazzola

  • Giulia Montori

  • Ferdinando Agresta

  • Jacopo Martellucci

  • Fausto Catena

  • Federico Coccolini

  • Gabriele Anania

  • Gianluca Costa

  • Vincenzo Bottino

  • Nicola Cillara

  • Paolo Prosperi

  • Carlo Bergamini

  • Mauro Podda

  • June 3, 2026

  • 0 min

Share

Objective:

To compare colonic stenting as a bridge to surgery with emergency surgery in the management of malignant left-sided large bowel obstruction.

Approach:
    Key Findings:
    • The study aims to evaluate the safety and efficacy of SEMS versus emergency surgery.
    • SEMS placement is intended to convert emergency scenarios into elective settings.
    • Controversial results exist regarding the impact of colonic stenting on complications and survival.
    Interpretation:

    The study seeks to clarify the role of SEMS in managing obstructive left-sided colon cancer compared to traditional emergency surgery.

    Limitations:
    • Non-randomized treatment allocation may introduce bias.
    • Differences in baseline characteristics could influence outcomes.
    Conclusion:

    The findings will contribute to understanding the optimal management strategies for obstructive left-sided colon cancer.

    Sources:

Original Source(s)

Colonic resection or self-expanding metal stents for obstructive left colon cancer: results of a national multicenter prospective cohort study (CROSCO-1)

  • by Alessio Giordano, Manuela Mastronardi, Paola Fugazzola, Giulia Montori, Ferdinando Agresta, Jacopo Martellucci, Fausto Catena, Federico Coccolini, Gabriele Anania, Gianluca Costa, Vincenzo Bottino, Nicola Cillara, Paolo Prosperi, Carlo Bergamini, Mauro Podda

  • June 3, 2026

Related Content

HDAC1-mediated CDK1 decrotonylation inhibits colorectal cancer proliferation by regulating cell cycle and apoptosis

Immune–tumor cell ligand–receptor axes driving metabolic reprogramming and therapeutic resistance in cancer

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma